{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:00:07Z","timestamp":1790452807238,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019751","name":"JSS Academy of Higher Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejps.2026.107663","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:11:09Z","timestamp":1789085469000},"page":"107663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biological Investigation of Novel Pyrazole-Based Anticancer Scaffolds: A Trinity of Synthetic Methodologies on Computational Assessment of IC50 Against Human Cancer Cell Lines MCF-7, MDA-MB and HeLa"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0297-6301","authenticated-orcid":false,"given":"Pooja","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandkumar","family":"Tengli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ejps.2026.107663_bib0001","first-page":"4827","article-title":"Evaluation of a soluble tetrazolium\/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines","volume":"48","author":"Scudiero","year":"1988","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"10.1016\/j.ejps.2026.107663_bib0002","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ejps.2026.107663_bib0003","doi-asserted-by":"crossref","DOI":"10.1590\/1678-9199-jvatitd-2019-0047","article-title":"Anticancer potential of nanogold conjugated toxin GNP-NN-32 from Naja naja venom","volume":"26","author":"Attarde","year":"2020","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"issue":"1\u20132","key":"10.1016\/j.ejps.2026.107663_bib0004","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0022-1759(86)90215-2","article-title":"Use of MTT colorimetric assay to measure cell activation","volume":"94","author":"Gerlier","year":"1986","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ejps.2026.107663_bib0005","unstructured":"health enews | A news service from Advocate Aurora Health."},{"key":"10.1016\/j.ejps.2026.107663_bib0006","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1093\/emboj\/17.11.3052","article-title":"A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers","volume":"17","author":"Bischoff","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.ejps.2026.107663_bib0007","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/2496","article-title":"Tumour amplified kinase STK15\/BTAK induces centrosome amplification, aneuploidy and transformation","volume":"20","author":"Zhou","year":"1998","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.ejps.2026.107663_bib0008","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1038\/bjc.2013.608","article-title":"Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis","volume":"109","author":"JA","year":"2013","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ejps.2026.107663_bib0009","first-page":"1","article-title":"The expression of AURKA is androgen regulated in castration-resistant prostate cancer","volume":"7","author":"Kivinummi","year":"2017","journal-title":"Sci Reports"},{"issue":"1","key":"10.1016\/j.ejps.2026.107663_bib0010","article-title":"Aurora Kinase A expression is associated with lung cancer histological-subtypes and with tumor de-differentiation","volume":"9","author":"M","year":"2011","journal-title":"J Transl Med"},{"key":"10.1016\/j.ejps.2026.107663_bib0011","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fonc.2015.00295","article-title":"Aurora-A Kinase as a Promising Therapeutic Target in Cancer","volume":"5","author":"D\u2019Assoro","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejps.2026.107663_bib0012","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/816430","article-title":"A New Aurora in Anaplastic Thyroid Cancer Therapy","author":"Baldini","year":"2014","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.ejps.2026.107663_bib0013","article-title":"Worldwide cancer data, World Cancer Research Fund","year":"2018","journal-title":"Cancer Facts & Figures for African Americans 2016-2018"},{"key":"10.1016\/j.ejps.2026.107663_bib0014","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrm1245","article-title":"The cellular geography of Aurora kinases","volume":"4","author":"Carmena","year":"2003","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/j.ejps.2026.107663_bib0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/0118756921288305240408084708","article-title":"Pharmacogenomics: Importance in Exploration of Target Molecule, Drug Resistance and Mechanism in Cancer Chemotherapy","volume":"21","author":"Kumari","year":"2024","journal-title":"Curr Pharmacogenomics Person Med"},{"key":"10.1016\/j.ejps.2026.107663_bib0016","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nm1003","article-title":"VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo","volume":"10","author":"Harrington","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.ejps.2026.107663_bib0017","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/1535-7163.MCT-07-2051","article-title":"Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells","volume":"7","author":"D\u2019Alise","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ejps.2026.107663_bib0018","first-page":"141","article-title":"A novel class of pyrazole analogues as aurora kinase A inhibitor: design, synthesis, and anticancer evaluation","author":"Yevale","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.ejps.2026.107663_bib0019","first-page":"1337","article-title":"Synthesis of furan-based pyrazoline as an anticancer agent: An in vitro and in silico approach toward COX-2 inhibition","author":"Ghifari","year":"2025","journal-title":"J Mol Struct"},{"issue":"23","key":"10.1016\/j.ejps.2026.107663_bib0020","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.2174\/0929867330666230503124408","article-title":"Recent Updates on Oncogenic Signaling of Aurora Kinases in Chemosensitive, Chemoresistant Cancers: Novel Medicinal Chemistry Approaches for Targeting Aurora Kinases","volume":"31","author":"Kumari","year":"2023","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.ejps.2026.107663_bib0021","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejps.2026.107663_bib0022","first-page":"1","article-title":"Global cancer observatory","volume":"593","year":"2019","journal-title":"Malaysia Cancer Statistics"},{"key":"10.1016\/j.ejps.2026.107663_bib0023","article-title":"The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide","author":"Filho","year":"2024","journal-title":"Int J cancer"},{"issue":"20","key":"10.1016\/j.ejps.2026.107663_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14205006","article-title":"Upregulation of Receptor Tyrosine Kinase Activity and Stemness as Resistance Mechanisms to Akt Inhibitors in Breast Cancer","volume":"14","author":"Tsang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejps.2026.107663_bib0025","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.1021\/jm060897w","article-title":"1,4,5,6-Tetrahydropyrrolo[3,4-c]pyrazoles: Identification of a potent aurora kinase inhibitor with a favorable antitumor kinase inhibition profile","volume":"49","author":"Fancelli","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.ejps.2026.107663_bib0026","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/jm801270e","article-title":"Structure-based drug design of novel aurora kinase a inhibitors: Structural basis for potency and specificity","volume":"52","author":"Coumar","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.ejps.2026.107663_bib0027","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1021\/jm800984v","article-title":"Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity","volume":"52","author":"Howard","year":"2009","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.ejps.2026.107663_bib0028","first-page":"1","article-title":"AurkA controls self-renewal of breast cancer-initiating cells promoting wnt3a stabilization through suppression of miR-128","volume":"6","author":"Eterno","year":"2016","journal-title":"Sci Reports"},{"issue":"1","key":"10.1016\/j.ejps.2026.107663_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-016-0238-7","article-title":"Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients","volume":"9","author":"Mignogna","year":"2016","journal-title":"J Ovarian Res"},{"issue":"8","key":"10.1016\/j.ejps.2026.107663_bib0030","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.molonc.2014.05.012","article-title":"AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers","volume":"8","author":"A","year":"2014","journal-title":"Mol Oncol"},{"issue":"9","key":"10.1016\/j.ejps.2026.107663_bib0031","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1038\/bjc.2013.608","article-title":"Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis","volume":"109","author":"Goos","year":"2013","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ejps.2026.107663_bib0032","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5114\/aoms.2019.91351","article-title":"MicroRNA-490-3p suppresses hepatocellular carcinoma cell proliferation and migration by targeting the aurora kinase A gene (AURKA)","volume":"16","author":"Zhang","year":"2020","journal-title":"Arch Med Sci"},{"issue":"35","key":"10.1016\/j.ejps.2026.107663_bib0033","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1038\/sj.onc.1209494","article-title":"AURKA is one of the downstream targets of MAPK1\/ERK2 in pancreatic cancer","volume":"25","author":"T","year":"2006","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ejps.2026.107663_bib0034","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/onc.2014.14","article-title":"The Aurora Kinases in Cell Cycle and Leukemia","volume":"34","author":"Goldenson","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ejps.2026.107663_bib0035","article-title":"Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its","volume":"7","author":"Mobley","year":"2017","journal-title":"Aggressive Behavior. Sci Rep."},{"issue":"1","key":"10.1016\/j.ejps.2026.107663_bib0036","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4132\/jptm.2016.10.17","article-title":"Aurora Kinase A Is a Prognostic Marker in Colorectal Adenocarcinoma","volume":"51","author":"Koh","year":"2017","journal-title":"J Pathol Transl Med"},{"issue":"1","key":"10.1016\/j.ejps.2026.107663_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-015-0375-4","article-title":"Aurora kinase A in gastrointestinal cancers: time to target","volume":"14","author":"Katsha","year":"2015","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ejps.2026.107663_bib0038","doi-asserted-by":"crossref","first-page":"326","DOI":"10.15537\/1658-3175.8333","article-title":"Global cancer burden growing, amidst mounting need for services","volume":"45","year":"2024","journal-title":"Saudi Medical Journal"},{"key":"10.1016\/j.ejps.2026.107663_bib0039","series-title":"Facts & Figures 2024","year":"2024"},{"key":"10.1016\/j.ejps.2026.107663_bib0040","unstructured":"Breast cancer."},{"issue":"21","key":"10.1016\/j.ejps.2026.107663_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215205","article-title":"Role of Immunotherapy in the Treatment of Cancer: A Systematic Review","volume":"14","author":"Ling","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.ejps.2026.107663_bib0042","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/s12276-022-00864-3","article-title":"Molecular targeted therapy for anticancer treatment","volume":"54","author":"Min","year":"2022","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.ejps.2026.107663_bib0043","first-page":"1350","article-title":"Exploring pyrimidine scaffolds for cancer therapy: A triad of synthetic chemistry, computational studies, and in-vitro biological testing","author":"Kumari","year":"2026","journal-title":"J Mol Struct"},{"key":"10.1016\/j.ejps.2026.107663_bib0044","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.2174\/0929867330666230503124408","article-title":"Recent Updates on Oncogenic Signaling of Aurora Kinases in Chemosensitive, Chemoresistant Cancers: Novel Medicinal Chemistry Approaches for Targeting Aurora Kinases","volume":"31","author":"Kumari","year":"2023","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ejps.2026.107663_bib0045","first-page":"4827","article-title":"Evaluation of a Soluble Tetrazolium\/Formazan Assay for Cell Growth and Drug Sensitivity in Culture Using Human and Other Tumor Cell Lines","volume":"48","author":"Scudiero","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejps.2026.107663_bib0046","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ejps.2026.107663_bib0047","doi-asserted-by":"crossref","DOI":"10.1590\/1678-9199-jvatitd-2019-0047","article-title":"Anticancer potential of nanogold conjugated toxin GNP-NN-32 from Naja naja venom","volume":"26","author":"Attarde","year":"2020","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"10.1016\/j.ejps.2026.107663_bib0048","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.3891\/acta.chem.scand.27-1845","article-title":"The Structure of Pyrazole, C3H4N2, at 295 K and 108 K as determined by X-Ray Diffraction","volume":"27","author":"La","year":"1973","journal-title":"Acta Chem Scand"},{"issue":"2","key":"10.1016\/j.ejps.2026.107663_bib0049","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1021\/jm800984v","article-title":"Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity","volume":"52","author":"Howard","year":"2009","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.ejps.2026.107663_bib0050","first-page":"330","article-title":"Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011\u20132020)","volume":"27","author":"El-gamal","year":"2022","journal-title":"Current Status and Future Prospects. Molecules"},{"issue":"5","key":"10.1016\/j.ejps.2026.107663_bib0051","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/1535-7163.MCT-07-2051","article-title":"Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells","volume":"7","author":"D\u2019Alise","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"10.1016\/j.ejps.2026.107663_bib0052","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nm1003","article-title":"VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo","volume":"10","author":"Harrington","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.ejps.2026.107663_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.144013","article-title":"Exploring pyrimidine scaffolds for cancer therapy: A triad of synthetic chemistry, computational studies, and in-vitro biological testing","volume":"1350","author":"Kumari","year":"2026","journal-title":"J Mol Struct"},{"key":"10.1016\/j.ejps.2026.107663_bib0054","first-page":"200","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update","author":"Roskoski","year":"2024","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.ejps.2026.107663_bib0055","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00280-009-1076-8","article-title":"SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo","volume":"65","author":"Arbitrario","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.1016\/j.ejps.2026.107663_bib0056","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1083\/jcb.200208091","article-title":"Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores","volume":"161","author":"Ditchfield","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ejps.2026.107663_bib0057","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1158\/1078-0432.CCR-06-2979","article-title":"AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis","volume":"13","author":"Wilkinson","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ejps.2026.107663_bib0058","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1021\/jm800984v","article-title":"Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity","volume":"52","author":"Howard","year":"2009","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.ejps.2026.107663_bib0059","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nm1003","article-title":"VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo","volume":"10","author":"Harrington","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.ejps.2026.107663_bib0060","first-page":"589","article-title":"Feasibility of Drug Screening with Panels of Human Tumor Cell Lines Using a Microculture Tetrazolium Assay","volume":"48","author":"Alley","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejps.2026.107663_bib0061","doi-asserted-by":"crossref","DOI":"10.1590\/1678-9199-jvatitd-2019-0047","article-title":"Anticancer potential of nanogold conjugated toxin GNP-NN-32 from Naja naja venom","volume":"26","author":"Attarde","year":"2020","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"10.1016\/j.ejps.2026.107663_bib0062","unstructured":"HiMedia Leading BioSciences Company."},{"issue":"11","key":"10.1016\/j.ejps.2026.107663_bib0063","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0186208","article-title":"Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC)","volume":"12","author":"Anantharaju","year":"2017","journal-title":"PLoS One"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872600237X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872600237X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:38:44Z","timestamp":1790451524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809872600237X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":63,"alternative-id":["S092809872600237X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107663","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological Investigation of Novel Pyrazole-Based Anticancer Scaffolds: A Trinity of Synthetic Methodologies on Computational Assessment of IC50 Against Human Cancer Cell Lines MCF-7, MDA-MB and HeLa","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107663"}}